JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Signaling Pathways

Signaling Pathways

A8320 PF-00562271

Target: FAK|Pyk2

Summary: FAK/Pyk2 inhibitor,potent and ATP-competitive

insoluble in EtOH; insoluble in H2O; ≥11.1 mg/mL
A8321 Cisplatin

5 Citation

Summary: Inhibits DNA synthesis,chemotherapy drug
A8322 Neratinib (HKI-272)

1 Citation

Target: EGFR

Summary: HER2/EGFR inhibitor,potent and irreversible

insoluble in H2O; ≥13.93 mg/mL
A8323 WP1130

1 Citation

Summary: Deubiquitinase (DUB) inhibitor, Cell permeable

≥38.4 mg/mL
A8324 LDN-193189

Target: BMP and Other Activin Receptors

Summary: ALK inhibitor,potent and selective

insoluble in DMSO; insoluble in EtOH; insoluble in H2O
A8325 Tivantinib (ARQ 197)

2 Citation

Target: MET

Summary: C-Met inhibitor,non-ATP-competitive

≥18.47 mg/mL
A8326 AZD-5438

2 Citation

Target: Cyclin-Dependent Kinases

Summary: Potent CDK1/2/9 inhibitor

insoluble in H2O; ≥18.55 mg/mL
A8327 Verteporfin

Target: YAP

Summary: Photosensitizer used in photodynamic therapy

insoluble in EtOH; insoluble in H2O; ≥18.3 mg/mL
A8328 LDK378

Target: ALK

Summary: Potent ALK inhibitor

insoluble in H2O; ≥13.95 mg/mL
A8329 R428

10 Citation

Summary: Selective Axl inhibitor

≥25 mg/mL